Papers: 10.1007/s00259-021-05237-y

https://doi.org/10.1007/s00259-021-05237-y

Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review

Cited by: 23
Author(s): Reyhaneh Manafi‐Farid, Sara Harsini, Bahare Saidi, Hojat Ahmadzadehfar, Ken Herrmann, Alberto Briganti, Jochen Walz, Mohsen Beheshti
Published: over 5 years ago

Software Mentions 1